Drug price regulator NPPA (National Pharmaceutical Pricing Authority) has announced provisional ceiling prices of 761 medicines, including anti-cancer, HIV, diabetes and antibiotic, with a majority being reduced ahead of the GST implementation.
The Goods and Services Tax is to be rolled out from 1st of next month.
Talking to a news agency, NPPA Chairman Bhupendra Singh yesterday said, the actual increase or decrease in prices after the rollout of new indirect tax regime is expected to be in the range of 2-3 per cent depending on states.
He said, the authority has asked pharmaceutical firms to check the list and inform it if there is a need for any correction by tomorrow.
NPPA said, these prices will be notified as formal revised ceiling prices immediately after GST notification. As per the provisional list, ceiling price of various cancer drugs have been reduced.